| Douglas Santiago, | |
|
4713 West Ginger Avenue, Coolidge, AZ 85128 | |
| (480) 748-5702 | |
| Not Available |
| Full Name | Douglas Santiago |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 4713 West Ginger Avenue, Coolidge, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962682203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | DA6557 (Arizona) | Primary |
| Provider Name | Hearx West Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356398598 PECOS PAC ID: 3577535624 Enrollment ID: O20180713002238 |
News Archive
Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).
Cancer is rarely black and white, and it's no small matter no matter how small, but a new discovery in the field of cancer screenings has come to light that signals a shift to an earlier, more certain and specific cancer diagnosis.
Galapagos NV and Sareum Holdings plc has announced today that Galapagos has acquired Sareum's assets in drug discovery services, for a total cash consideration of EUR 695,000 (£553,000). These assets will position Galapagos' service division BioFocus DPI strongly in the growing field of structure-based drug discovery.
Kaiser Health News provides a fresh take on health policy developments with "And Call Me In The Morning" By Nick Anderson.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Santiago, 4713 W Ginger Ave, Coolidge, AZ 85128-8286 Ph: (480) 748-5702 | Douglas Santiago, 4713 West Ginger Avenue, Coolidge, AZ 85128 Ph: (480) 748-5702 |
News Archive
Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).
Cancer is rarely black and white, and it's no small matter no matter how small, but a new discovery in the field of cancer screenings has come to light that signals a shift to an earlier, more certain and specific cancer diagnosis.
Galapagos NV and Sareum Holdings plc has announced today that Galapagos has acquired Sareum's assets in drug discovery services, for a total cash consideration of EUR 695,000 (£553,000). These assets will position Galapagos' service division BioFocus DPI strongly in the growing field of structure-based drug discovery.
Kaiser Health News provides a fresh take on health policy developments with "And Call Me In The Morning" By Nick Anderson.
› Verified 6 days ago